<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A group of 20 patients (average age 55.5 yrs) with advanced arterioscleorosis obliterans and <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> were treated with pyridinolcarbamate </plain></SENT>
<SENT sid="1" pm="."><plain>Anginin was given for 6 months, 1,5--2 g. per day </plain></SENT>
<SENT sid="2" pm="."><plain>Observation period before, during and after the treatment lasted 2 yrs </plain></SENT>
<SENT sid="3" pm="."><plain>Medical and psychological examinations were performed; laboratory test included: sphigmooscylography, photoplethysmography, EKG, EEG, cholesterol, triglyceridis and other routine biochemical blood tests </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> data are statistically evaluated </plain></SENT>
<SENT sid="5" pm="."><plain>Results </plain></SENT>
<SENT sid="6" pm="."><plain>During Anginin treatment clinical improvement was noted in 8 cases, in 9 there was no change in neurological examination; 3 cases--deteriorated </plain></SENT>
<SENT sid="7" pm="."><plain>Control examination 6 to 12 months after discontinuation of the treatment revealed no changes in 13 patients; 1 patient deteriorated and 6--died </plain></SENT>
<SENT sid="8" pm="."><plain>There was improvement in blood circulation as shown by plethysmography and sphigmooscylography in patients with less advanced vascular changes and no change in cases with more advanced disease </plain></SENT>
<SENT sid="9" pm="."><plain>In 75% of the patients there was statistically significant (p less than 0.001) decrease of cholesterol and in 50% of triglicerids (not statistically significant) </plain></SENT>
<SENT sid="10" pm="."><plain>In patients with advanced disease there was no clinical and EEG improvement, on the contrary 1/3 of them deteriorated clinically and in EEG </plain></SENT>
<SENT sid="11" pm="."><plain>In cases with less advanced disease clinical improvement was recorded </plain></SENT>
<SENT sid="12" pm="."><plain>Anginin seems to be a good drug for patients with moderately advanced combined peripheral and central <z:hpo ids='HP_0002634'>arteriosclerosis</z:hpo> </plain></SENT>
</text></document>